PCN110 Economic Evaluation of Gefitinib for First-Line Treatment of EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Patients in Greece
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1211
https://www.valueinhealthjournal.com/article/S1098-3015(11)02773-2/fulltext
Title :
PCN110 Economic Evaluation of Gefitinib for First-Line Treatment of EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Patients in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02773-2&doi=10.1016/j.jval.2011.08.1211
First page :
A454
Section Title :
Cancer
Open access? :
No
Section Order :
1167